‘A Lot To Consider’ For Sponsors Planning Decentralized Trials
DCTs Come With New Sources Of Confounding Bias And Missing Data
A senior MHRA official tells sponsors not to get "put off" by the many factors they need to examine when deciding on the suitability of decentralized trials, and instead seek early advice from regulators.
